Novo Nordisk | Ativo Circulante



Current Assets Alterar Data
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.73B 42M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 174.4B 20.76B 2025-03
Novo Nordisk DKK 195.16B 17.66B 2024-09
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Sanofi 44.02B 1.43B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Zoetis USD 5.88B 109M 2025-03



Novo Nordisk Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.